Porte D Jr - Search Results

1

A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis.

Grotz VL, Pi-Sunyer X, Porte D Jr, Roberts A, Richard Trout J. Grotz VL, et al. Among authors: porte d jr. Regul Toxicol Pharmacol. 2017 Aug;88:22-33. doi: 10.1016/j.yrtph.2017.05.011. Epub 2017 May 11. Regul Toxicol Pharmacol. 2017. PMID: 28502831 Free article. Clinical Trial.

2

The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

Triplitt C, McGill JB, Porte D Jr, Conner CS. Triplitt C, et al. Among authors: porte d jr. J Manag Care Pharm. 2007 Dec;13(9 Suppl C):S2-16; quiz S17. doi: 10.18553/jmcp.2007.13.9-c.1. J Manag Care Pharm. 2007. PMID: 18062735 Free PMC article. Review.

3

Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans.

Porte D Jr, Baskin DG, Schwartz MW. Porte D Jr, et al. Diabetes. 2005 May;54(5):1264-76. doi: 10.2337/diabetes.54.5.1264. Diabetes. 2005. PMID: 15855309 Review.

4

Diabetes, obesity, and the brain.

Schwartz MW, Porte D Jr. Schwartz MW, et al. Among authors: porte d jr. Science. 2005 Jan 21;307(5708):375-9. doi: 10.1126/science.1104344. Science. 2005. PMID: 15662002

5

Leptin and insulin action in the central nervous system.

Porte D Jr, Baskin DG, Schwartz MW. Porte D Jr, et al. Nutr Rev. 2002 Oct;60(10 Pt 2):S20-9; discussion S68-84, 85-7. doi: 10.1301/002966402320634797. Nutr Rev. 2002. PMID: 12403080 Review.

6

Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.

Porte D Jr. Porte D Jr. Diabetes Metab Res Rev. 2001 May-Jun;17(3):181-8. doi: 10.1002/1520-7560(200105/06)17:3<181::aid-dmrr197>3.0.co;2-1. Diabetes Metab Res Rev. 2001. PMID: 11424231 Review.

7

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

Porte D Jr, Kahn SE. Porte D Jr, et al. Diabetes. 2001 Feb;50 Suppl 1:S160-3. doi: 10.2337/diabetes.50.2007.s160. Diabetes. 2001. PMID: 11272181 Review.

8

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr. Kahn SE, et al. Among authors: porte d jr. J Nutr. 2001 Feb;131(2):354S-60S. doi: 10.1093/jn/131.2.354S. J Nutr. 2001. PMID: 11160560 Review.

9

Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction.

Porte D Jr. Porte D Jr. Ann N Y Acad Sci. 1999 Nov 18;892:73-83. doi: 10.1111/j.1749-6632.1999.tb07786.x. Ann N Y Acad Sci. 1999. PMID: 10842653 Review.

10

Central nervous system control of food intake.

Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Schwartz MW, et al. Among authors: porte d jr. Nature. 2000 Apr 6;404(6778):661-71. doi: 10.1038/35007534. Nature. 2000. PMID: 10766253 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters